Tencent-Backed WeDoctor Scraps International Listing for Shanghai

The healthcare app creator reportedly shelves a Hong Kong listing in favor of "China's Nasdaq" due to data privacy and transparency concerns.

The One Geopolitical Event That Could Surprise Markets the Most

There's a lot going on right now and the markets (and media) have difficulty latching on to more than three or four stories at a time.

Hong Kong Strife Claims First Stock Exchange Victim as Tear Gas Wafts

A Hong Kong-listed mainland Chinese property developer has shelved the purchase of a billion-dollar land plot in the city, walking away from a hefty deposit. It blames political chaos.

Best and Worst Beer Stocks

Wetting my whistle with these 2 beer names, plus 2 stocks to avoid.

China's Drugmakers Under Scrutiny After Stanford Admissions Scandal

Chinese authorities are auditing the books of 77 drugmakers, including three multinationals, they say were selected at random. Were they motivated by embarrassment over a college-admissions payment made by a Chinese pharmaceuticals' tycoon?

Jim Cramer: Don't Buy the 'You Can Take Them Off' Rhetoric on Tariffs

Trade tariffs have a cost for everyone, despite what the administration might say.

The Market Is in Wait-and-See Mode on Trade and Interest Rates

It is tough to build a position in this murky market.

Jim Cramer: Salesforce Knows Its Customer, but Do These Other Tech Giants?

Dealing with fears around the trade war with China and antitrust investigations, investors should know not only if customers are doing well, but also who a company's customers really are.

Buckle Up, We May Already Be in a Recession

Growth will keep falling off a cliff unless Fed Powell comes to the rescue. But it is unclear whether he can, or will.

The Oracle of Omaha Is Off His Game

Be careful backing Buffett right now, his biggest holdings show increasing profit pressure.